Agosti S, Casalino L, Daffonchio A, Arena L, Celli L and Rota E
Idarucizumab is a monoclonal antibody which has been shown to be effective for rapid, durable, and safe reversal of the anticoagulant effect of dabigatran. We will describe herein the third case reported so far on the use of idarucizumab in a patient on dabigatran for nonvalvular atrial fibrillation and an indication for emergency lumbar puncture for suspected meningitis.
PDFShare this article
Journal of Clinical Case Reports received 1345 citations as per Google Scholar report